Relenza

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

InfluenzaDengue Fever

95 competitors in Influenza

#DrugCompanyPhaseTrials

1

Influenza Vaccine

Novartis

Phase 3

712

FLU Vaccine

GSK

Phase 3

83

Inactivated Influenza Vaccine

Sanofi

Phase 3

144

Seasonal Influenza Vaccine

Novartis

Phase 3

225

Live Attenuated Zoster Vaccine

CChangchun BCHT Biotechnology Co.

Phase 3

126

Avigan

AAppili Therapeutics Inc.

Phase 2

67

Relenza

GGlaxo Dba Glaxosmithkline

Phase 3

58

VAXIGRIP

GSK

Phase 3

89

Dexametasone

UUniversity of Malaya

Phase 3

110

Baloxavir

IInsight Therapeutics, LLC

Phase 3

3Show 27 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Influenza5 trials

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection

Completed·GSK·Phase 3·NCT01527110·21 enrolled

Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China

Completed·Jiangsu Simcere Pharmaceutical Co., Ltd.·Phase 3·NCT01459081·298 enrolled

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza

Completed·GSK·Phase 3·NCT01231620·626 enrolled

Show 2 more trials

Zanamivir Versus Trivalent Split Virus Influenza Vaccine

Completed·MMount Sinai Hospital, Canada·Phase 3·NCT00784784·64 enrolled

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Recruiting·UUniversity of Oxford·Phase 2·NCT05648448·3,000 enrolled

Tics1 trial

Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days

Completed·GSK·Phase 1·NCT00989404·18 enrolled

Intravenous1 trial

Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00921726·17 enrolled

Infusion1 trial

Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults

Completed·GSK·Phase 1·NCT02377401·24 enrolled

Swine Influenza1 trial

A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection

Terminated·—·Phase 3·NCT00979667·4 enrolled

4 more indications

Endothelial Dysfunction1 trial

Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes

Completed·UUniversity of Missouri-Columbia·Phase 2·NCT04867707·14 enrolled

Dengue Fever1 trial

Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE): A Pilot Randomized Controlled Trial

Recruiting·GGeorge Washington University·Phase 2·NCT04597437·74 enrolled

Influenza, Human1 trial

An Open Label, Single Arm Study to Evaluate Single and Multiple Dose Pharmacokinetics, Safety and Tolerability, and to Explore Clinical Outcomes of Treatment With Intravenous (IV) Zanamivir in Neonates and Infants Under 6 Months of Age With Confirmed Complicated Influenza Infection

Completed·GSK·Phase 2·NCT04494412·8 enrolled

Unspecified1 trial

Relenza® Sentinel Site Monitoring Program in Japan

Completed·GSK··NCT01199744·1,575 enrolled

Regulatory

FDA Approval Timeline[4]

Details

Drug Info

Related News